Lipoprotein based drug delivery: Potential for pediatric cancer applications

doi:10.5497/wjp.v4.i2.172

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6741)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

479

WORD

479

HTML

3186

Figures (1-1)

286

Tables (1-2)

203

Sum=4633

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

914

Download

1194

Sum=2108

Jun 9, 2015 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Pharmacol. Jun 9, 2015; 4(2): 172-179
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.172

Open in New Tab Full Size Figure Download Figure

Figure 1 Size and density distribution of lipoproteins. HDL: High density lipoprotein; IDL: Intermediate density lipoprotein; VLDL: Very low density lipoprotein; LDL: Low density lipoprotein.

Citation: Sabnis N, Bowman WP, Lacko AG. Lipoprotein based drug delivery: Potential for pediatric cancer applications. World J Pharmacol 2015; 4(2): 172-179
URL: https://www.wjgnet.com/2220-3192/full/v4/i2/172.htm
DOI: https://dx.doi.org/10.5497/wjp.v4.i2.172